Diabetic eye disease: A primary care perspective

被引:6
作者
Frank, KJ [1 ]
Dieckert, JP [1 ]
机构
[1] TEXAS A&M UNIV, HLTH SCI CTR, SCOTT SHERWOOD & BRINDLEY FDN, SCOTT & WHITE CLIN & MEM HOSP, TEMPLE, TX 76508 USA
关键词
D O I
10.1097/00007611-199605000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with diabetes are at risk for multiple visual complications, most notably diabetic retinopathy, but also glaucoma, cataracts, optic nerve disease, and strabismus. Diabetic retinopathy is the leading cause of blindness for the majority of Americans. Microvascular damage from diabetes leads to microaneurysms, hemorrhage, exudates, and cotton-wool spots. Further progression of disease leads to new vessel growth, or neovascularization. Growth of new blood vessels can cause severe hemorrhage, scarring, and permanent visual loss. Various randomized, prospective studies have clearly shown benefit from laser therapy at specific stages of progression of retinopathy. Proper referral and close follow-up are paramount to the preservation of visual function.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 25 条
  • [1] AIELLO LM, 1994, PRINCIPLES PRACTICE, P747
  • [2] *AM AC OPHTH, 1993, DIAB RET PREF PRACT, P24
  • [3] [Anonymous], 1988, OPHTHALMOLOGY, V95, P1307
  • [4] [Anonymous], 1985, Arch Ophthalmol, V103, P1644
  • [5] [Anonymous], 1981, OPHTHALMOLOGY, V88, P583
  • [6] BECKER B, 1971, AM J OPHTHALMOL, V71, P1
  • [7] Diabetic Retinopathy Study Research Group, 1987, INT OPHTHALMOL CLIN, V27, P239, DOI DOI 10.1097/00004397-198702740-00004
  • [8] GLASER JS, 1990, NEUROOPHTHALMOLOGY, P361
  • [9] VITRECTOMY IN THE MANAGEMENT OF DIABETIC EYE DISEASE
    HO, T
    SMIDDY, WE
    FLYNN, HW
    [J]. SURVEY OF OPHTHALMOLOGY, 1992, 37 (03) : 190 - 202
  • [10] JAVITT JC, 1989, OPHTHALMOLOGY, V96, P255